Artículos por temáticas

Vitamin D and Neurodegenerative Diseases Such as Multiple Sclerosis (MS), Parkinson's Disease (PD), Alzheimer's Disease (AD), and Amyotrophic Lateral Sclerosis (ALS): A Review of Current Literature

Savran Z, Baltaci SB, Aladag T, Mogulkoc R, Baltaci AK.

Curr Nutr Rep. 2025 Jun 4;14(1):77. doi: 10.1007/s13668-025-00663-y.

The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure

Hardy J, Escott-Price V.

Mol Psychiatry. 2025 Jun;30(6):2748-2753. doi: 10.1038/s41380-025-02911-7. Epub 2025 Jan 29.

Median nerve ultrasonography in Parkinson's disease: a systematic review and meta-analysis

Atwan H, Abdelaziz A, Kassem HA, Eltobgy M, Gamal M, Sleem A, Ebaid NY.

Int J Neurosci. 2025 Jun;135(6):731-739. doi: 10.1080/00207454.2024.2327407. Epub 2024 May 20.

Neuroimaging Meta-Analyses Reveal Convergence of Interoception, Emotion, and Social Cognition Across Neurodegenerative Diseases

Hazelton JL, Carneiro F, Maito M, Richter F, Legaz A, Altschuler F, Cubillos-Pinilla L, Chen Y, Doherty CP, Baez S, Ibáñez A.

Biol Psychiatry. 2025 Jun 1;97(11):1079-1090. doi: 10.1016/j.biopsych.2024.10.013. Epub 2024 Oct 21.

Alpha-Synuclein Seed Amplification Assays in Parkinson's Disease: A Systematic Review and Network Meta-Analysis

Rissardo JP, Fornari Caprara AL.

Clin Pract. 2025 Jun 3;15(6):107. doi: 10.3390/clinpract15060107.

Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders

Au HCT, Lam PH, Lim PK, McIntyre RS.

Neurosci Biobehav Rev. 2025 Jun;173:106159. doi: 10.1016/j.neubiorev.2025.106159. Epub 2025 Apr 17.

Transformative advances in modeling brain aging and longevity: Success, challenges and future directions

Pai V, Singh BN, Singh AK.

Ageing Res Rev. 2025 Jun;108:102753. doi: 10.1016/j.arr.2025.102753. Epub 2025 Apr 11.

Interoception in Parkinson's disease: A narrative review and framework for translational research

Longardner K, Mabry SA, Chen G, Freeman R, Khalsa SS, Beach P.

Auton Neurosci. 2025 Jun;259:103258. doi: 10.1016/j.autneu.2025.103258. Epub 2025 Mar 8.

Phenotypic comparison between combined dystonia-parkinsonism and idiopathic adult-onset dystonia

Idrissi S, Erro R, Mascia MM, Trinchillo A, Esposito M, Velucci V, Pellicciari R, Ceravolo R, Cotelli MS, Schirinzi T, Cassano D, Castagna A, Altavista MC, Terranova C, Magistrelli L, Belvisi D, Ferra

J Neural Transm (Vienna). 2025 Jun;132(6):803-810. doi: 10.1007/s00702-025-02920-4. Epub 2025 Apr 17.

Clearance Pathways for α-Synuclein in Parkinson's Disease

Ho MS.

J Neurochem. 2025 Jun;169(6):e70124. doi: 10.1111/jnc.70124.

Noninvasive Vagus Nerve Stimulation in Parkinson's Disease: A Systematic Review

Eissazade N, Eghdami S, Rohani M, Ajdari A, Fereshtehnejad SM, Fasano A, Khoeini T.

Neuromodulation. 2025 Jun;28(4):641-651. doi: 10.1016/j.neurom.2025.01.012. Epub 2025 Mar 6.

Cannabidiol and cognitive functions/inflammatory markers in Parkinson's disease: A double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial)

Mitarnun W, Kanjanarangsichai A, Junlaor P, Kongngern L, Mitarnun W, Pangwong W, Nonghan P.

Parkinsonism Relat Disord. 2025 Jun;135:107841. doi: 10.1016/j.parkreldis.2025.107841. Epub 2025 Apr 16.

Alexithymia in Parkinson's Disease: A Meta-analysis

Fernández-Fernández R, Ibias J, Del Toro-Pérez C, Lahera G, Gasca-Salas C.

Am J Geriatr Psychiatry. 2025 Jun;33(6):638-653. doi: 10.1016/j.jagp.2024.11.009. Epub 2024 Dec 2.

[Subtypes of Parkinson's disease]

Ebersbach G.

Fortschr Neurol Psychiatr. 2025 Jun;93(6):243-254. doi: 10.1055/a-2521-3214. Epub 2025 Jun 10.

Neurology of Androgens and Androgenic Supplements

Dengri C, Mayberry W, Koriesh A, Nouh A.

Curr Neurol Neurosci Rep. 2025 Jun 3;25(1):39. doi: 10.1007/s11910-025-01426-6.